多奈哌齐治疗唐氏综合征相关阿尔茨海默病的不良反应。 - Suppr

Suppr

超能文献

Adverse effects of donepezil in treating Alzheimer's disease associated with Down's syndrome.

作者信息

Hemingway-Eltomey J M, Lerner A J

出版信息

Am J Psychiatry. 1999 Sep;156(9):1470. doi: 10.1176/ajp.156.9.1470.

DOI:10.1176/ajp.156.9.1470

PMID:10484967

Abstract

摘要

相似文献

Adverse effects of donepezil in treating Alzheimer's disease associated with Down's syndrome.

Am J Psychiatry. 1999 Sep;156(9):1470. doi: 10.1176/ajp.156.9.1470.

Donepezil for Down's syndrome.

Am J Psychiatry. 2001 Jan;158(1):143. doi: 10.1176/appi.ajp.158.1.143.

Cholinesterase inhibitor treatment and urinary incontinence in Alzheimer's disease.

J Am Geriatr Soc. 2007 May;55(5):800-1. doi: 10.1111/j.1532-5415.2007.01143.x.

Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study.

Int J Geriatr Psychiatry. 2003 Jun;18(6):549-51. doi: 10.1002/gps.859.

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease--pilot study.

Int J Geriatr Psychiatry. 2002 Mar;17(3):270-8. doi: 10.1002/gps.587.

Urinary incontinence: an unrecognised adverse effect with donepezil.

Lancet. 2000 Aug 12;356(9229):568. doi: 10.1016/S0140-6736(00)02588-5.

Behavioral complications associated with donepezil.

Am J Psychiatry. 1998 Nov;155(11):1632-3.

Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.

Int J Geriatr Psychiatry. 2008 Sep;23(9):979-81. doi: 10.1002/gps.1979.

Pisa syndrome due to a cholinesterase inhibitor (donepezil): a case report.

J Clin Psychiatry. 2001 Jul;62(7):573-4. doi: 10.4088/jcp.v62n07d13.

Donepezil for severe Alzheimer's disease.

Lancet. 2006 Jul 29;368(9533):361-2; author reply 362. doi: 10.1016/S0140-6736(06)69098-3.

引用本文的文献

Aging With Down Syndrome: The Dual Diagnosis: Alzheimer's Disease and Down Syndrome.

Am J Alzheimers Dis Other Demen. 2018 Jun;33(4):253-262. doi: 10.1177/1533317518761093. Epub 2018 Mar 5.

Urinary Incontinence in Alzheimer's Disease.

Am J Alzheimers Dis Other Demen. 2017 Feb;32(1):51-55. doi: 10.1177/1533317516680900. Epub 2016 Dec 18.

Pharmacotherapeutic Considerations for Individuals with Down Syndrome.

Pharmacotherapy. 2017 Feb;37(2):214-220. doi: 10.1002/phar.1880. Epub 2017 Jan 13.

Pharmacokinetics of Chemotherapeutic Drugs in Pediatric Patients With Down Syndrome and Leukemia.

J Pediatr Hematol Oncol. 2016 May;38(4):283-7. doi: 10.1097/MPH.0000000000000540.

Rationale for the use of anticholinergic agents in overactive bladder with regard to central nervous system and cardiovascular system side effects.

Korean J Urol. 2013 Dec;54(12):806-15. doi: 10.4111/kju.2013.54.12.806. Epub 2013 Dec 10.

Vulnerable elderly patients and overactive bladder syndrome.

Drugs Aging. 2010 Sep 1;27(9):697-713. doi: 10.2165/11539020-000000000-00000.

Donepezil for dementia in people with Down syndrome.

Cochrane Database Syst Rev. 2009 Jan 21;2009(1):CD007178. doi: 10.1002/14651858.CD007178.pub2.

Safety and efficacy of rivastigmine in adolescents with Down syndrome: a preliminary 20-week, open-label study.

J Child Adolesc Psychopharmacol. 2006 Dec;16(6):755-65. doi: 10.1089/cap.2006.16.755.

Donepezil for the treatment of language deficits in adults with Down syndrome: a preliminary 24-week open trial.

Am J Med Genet A. 2003 Jan 15;116A(2):111-6. doi: 10.1002/ajmg.a.10074.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验